Zu allen Mitgliedern

Marc Brehme

Dr. Marc Brehme is CTO of Ribbon Biolabs GmbH, a Vienna based biotech start-up company that introduces new approaches for the synthesis of long DNA molecules for biotech and biopharma.
Dr. Brehme’s interests center on the use of innovative approaches to tackling bottlenecks and challenges in personalised medicine, such as the accelerated development of personalised and improved biologic drugs. Dr. Brehme is committed within the ÖPPM to promote scientific avenues toward personalised medicine in general, and especially also as regards the positioning, communication and integration of molecular systems biology methodologies, synthetic biology technologies and associated capabilities in enabling the next generation of designed therapeutics for personalised medicine.

Additional Information:

Zu allen Mitgliedern